Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 2
1946 1
1952 1
1954 1
1955 2
1956 3
1957 1
1958 1
1961 3
1962 6
1963 7
1964 5
1965 5
1966 5
1967 3
1968 6
1969 5
1970 5
1971 1
1972 1
1973 1
1975 3
1976 3
1977 4
1979 1
1981 1
1982 6
1983 6
1984 4
1985 4
1986 5
1987 5
1988 7
1989 4
1990 15
1991 12
1992 7
1993 10
1994 17
1995 17
1996 17
1997 15
1998 22
1999 11
2000 17
2001 13
2002 15
2003 15
2004 37
2005 34
2006 33
2007 39
2008 39
2009 42
2010 49
2011 50
2012 48
2013 58
2014 59
2015 63
2016 49
2017 54
2018 50
2019 52
2020 59
2021 77
2022 56
Text availability
Article attribute
Article type
Publication date

Search Results

1,158 results
Results by year
Filters applied: . Clear all
Page 1
Cereblon enhancer methylation and IMiD resistance in multiple myeloma.
Haertle L, Barrio S, Munawar U, Han S, Zhou X, Vogt C, Fernández RA, Bittrich M, Ruiz-Heredia Y, Da Viá M, Zovko J, Garitano-Trojaola A, Bolli N, Ruckdeschel A, Stühmer T, Chatterjee M, Kull M, Krönke J, Agirre X, Martin-Subero JI, Raab P, Einsele H, Rasche L, Martinez-Lopez J, Haaf T, Kortüm KM. Haertle L, et al. Among authors: chatterjee m. Blood. 2021 Nov 4;138(18):1721-1726. doi: 10.1182/blood.2020010452. Blood. 2021. PMID: 34115836
Stepping Stones.
Chatterjee M. Chatterjee M. Indian J Dermatol. 2021 Jan-Feb;66(1):1-2. doi: 10.4103/0019-5154.308514. Indian J Dermatol. 2021. PMID: 33911287 Free PMC article. No abstract available.
Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma.
Da Vià MC, Dietrich O, Truger M, Arampatzi P, Duell J, Heidemeier A, Zhou X, Danhof S, Kraus S, Chatterjee M, Meggendorfer M, Twardziok S, Goebeler ME, Topp MS, Hudecek M, Prommersberger S, Hege K, Kaiser S, Fuhr V, Weinhold N, Rosenwald A, Erhard F, Haferlach C, Einsele H, Kortüm KM, Saliba AE, Rasche L. Da Vià MC, et al. Among authors: chatterjee m. Nat Med. 2021 Apr;27(4):616-619. doi: 10.1038/s41591-021-01245-5. Epub 2021 Feb 22. Nat Med. 2021. PMID: 33619368 Clinical Trial.
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings.
Hummel HD, Kufer P, Grüllich C, Seggewiss-Bernhardt R, Deschler-Baier B, Chatterjee M, Goebeler ME, Miller K, de Santis M, Loidl W, Dittrich C, Buck A, Lapa C, Thurner A, Wittemer-Rump S, Koca G, Boix O, Döcke WD, Finnern R, Kusi H, Ajavon-Hartmann A, Stienen S, Sayehli CM, Polat B, Bargou RC. Hummel HD, et al. Among authors: chatterjee m. Immunotherapy. 2021 Feb;13(2):125-141. doi: 10.2217/imt-2020-0256. Epub 2020 Nov 10. Immunotherapy. 2021. PMID: 33172323 Free article. Clinical Trial.
GPIIb/IIIa-GPVI-commanded platelet patrol.
Chatterjee M. Chatterjee M. Blood. 2022 Jul 14;140(2):81-83. doi: 10.1182/blood.2022016697. Blood. 2022. PMID: 35834285 No abstract available.
Samir Kumar Chatterjee.
Chatterjee M. Chatterjee M. BMJ. 2016 Aug 12;354:i4395. doi: 10.1136/bmj.i4395. BMJ. 2016. PMID: 27519424 No abstract available.
Platelet ACKR3/CXCR7 favors antiplatelet lipids over an atherothrombotic lipidome and regulates thromboinflammation.
Cebo M, Dittrich K, Fu X, Manke MC, Emschermann F, Rheinlaender J, von Eysmondt H, Ferreirós N, Sudman J, Witte A, Pelzl L, Borst O, Geisler T, Rath D, Bakchoul T, Gawaz M, Schäffer TE, Lämmerhofer M, Chatterjee M. Cebo M, et al. Among authors: chatterjee m. Blood. 2022 Mar 17;139(11):1722-1742. doi: 10.1182/blood.2021013097. Blood. 2022. PMID: 34905596
Voice emotion perception and production in cochlear implant users.
Jiam NT, Caldwell M, Deroche ML, Chatterjee M, Limb CJ. Jiam NT, et al. Among authors: chatterjee m. Hear Res. 2017 Sep;352:30-39. doi: 10.1016/j.heares.2017.01.006. Epub 2017 Jan 11. Hear Res. 2017. PMID: 28088500 Free PMC article. Review.
1,158 results